Cancer Drug Discovery & Preclinical Development

17th September - 18th September 2014 | London, UK
Active Communications International (ACI)

ACI’s Cancer Drug Discovery & Preclinical Development conference takes place in London, UK on 17th & 18th September 2014. This keystone event will focus on the early stages of cancer drug research, with interactive debate and detailed presentations on a wide range of topics. A diverse range of academic and industry experts will be there to ensure fair and balanced coverage of the latest developments in the field. All this takes place in a friendly environment designed to encourage networking between attendees

Key Topics

  • Strategies for the identification of selective kinase inhibitors
  • Overcoming mechanisms of drug resistance with new targeted anti-cancer therapies
  • New therapeutic targets in epigenetics and newly described metabolic pathways
  • DNA-targeted agents as part of a personalised approach to drug discovery
  • Methods for establishing pharmacologically safe and effective dose in animal studies
  • Engineering antibodies for targeted cancer therapy
  • Preparing for exploratory development

Why Attend?


  • Meet experts from the world of early-stage cancer drug development
  • Analyse trends in drug discovery within both academia and industry
  • Explore the road from discovery to development to final approval
  • Learn about the latest computer-aided drug design technologies
  • Hear case histories on drug discovery and preclinical development

Confirmed Speakers

Tao You, Systems Biologist, AstraZeneca

Sean Kitson, Investigator of Radiochemistry, Almac Group

Aliki Taylor, Observational Research Director, Amgen

Graham Smith, Team Leader, PET Radiochemistry, The Institute for Cancer Research

Steven Whittaker, Team Leader, Career Development Faculty, The Institute for Cancer Research

Angela Kukula, Director of Enterprise, The Institute for Cancer Research

Tim Hammonds, Deputy Director of Discovery, Cancer Research Technology

José Alfón, Vice President, Research and Development, Ability Pharmaceuticals

Who Should Attend?

Research Scientists, Team Leaders, Heads, Managers, Directors and other professionals working in the following areas related to oncology:

  • Drug Discovery
  • Preclinical Development
  • Exploratory Development
  • Medicinal Chemistry
  • Computational chemistry
  • Formulation
  • Targeted therapeutics
  • Translational Medicine
  • Personalised medicine
  • Genetics
  • Regulatory Affairs
  • Data Management

More Information:

Rohan Baryah

Tel: +48 (0) 616 467 022


Sponsorship and Commercial Opportunities

Victor Kinlock

Tel:  +44 (0)20 3141 0626


Speaking Opportunities:

Ciaran Larkin

Tel: +44 (0)20 3141 0625